Private company
Hyundai Bioscience
Hyundai Bioscience is a South Korean company based in North Gyeongsang, founded in 2000.1
현대바이오사이언스(영어: Hyundai Bioscience Co. Ltd.)는 대한민국의 약물전달체(DDS) 기술 전문 회사이다.2 From the Korean Wikipedia, CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
2000Founded1
- HeadquartersNorth Gyeongsang, South Korea1
- Websitewww.hyundaiibt.com
- Listed onKorea Exchange (Stock Market)1
Timeline
- 2000Founded Founded1
Calendar
Drug trials and FDA: coming up
- Jan 2027Phase 2/3 trial readout expected Phase 2/3 trial of CP-COV03 in Dengue: primary completion expected Jan 2027 (ClinicalTrials.gov NCT07576868).3
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar
Links
- Websitewww.hyundaiibt.com1
- WikidataQ17689072
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataHyundai Bioscience on Wikidata
- 2
- 3